Newsroom
Zhifei and GSK reached strategic cooperation, adding a new blockbuster...
Zhifei and GSK reached strategic cooperation, adding a new blockbuster product
2023-10-12
On October 8, 2023, Chongqing Zhifei Biological Products Co., Ltd. (hereinafter referred to as "Zhifei") and GlaxoSmithKline (GSK Biologica...
see details 》
Zhifei Longcom Recombinant COVID-19 Vaccine Receives Marketing Approva...
Zhifei Longcom Recombinant COVID-19 Vaccine Receives Marketing Approval in Kenya
2022-12-23
On December 22, the Company's Recombinant COVID-19 Vaccine (CHO Cell) was approved for marketing by the Pharmacy and Poisons Board (PPB) of...
Zhifei Longcom Passes EU QP Audit, An Acceleration in Zhifei’s Intern...
Zhifei Longcom Passes EU QP Audit, An Acceleration in Zhifei’s International Strategic Layout
2022-11-09
On November 8, 2022, the Recombinant COVID-19 Vaccine (CHO Cell) and the Recombinant COVID-19 Omicron-Delta Variant Vaccine (CHO Cell) of An...
Zhifei Lvzhu and Intravacc Reach Collaboration on Developing a Novel Pertussis Vaccine2022-04-30
Beijing, China, April 29, 2022 - Beijing Zhifei Lvzhu Biopharmaceutical Co., Ltd. (“Zhifei Lvzhu”), a wholly owned subsidiary of...
Recombinant COVID-19 Vaccine (CHO Cell) Included in List of COVID-19 Vaccines for Exportation2022-04-21
Recently, Ministry of Commerce, Ministry of Industry and Information Technology, National Health Commission and the National Medical Product...
China’s First Recombinant Protein Subunit COVID-19 Vaccine Received Conditional Marketing Approval2022-04-20
On March 1, 2022, the Recombinant COVID-19 Vaccine (CHO Cell) developed by Zhifei Longcom has received Conditional Marketing Authorization (...
Recombinant COVID-19 Vaccine (CHO Cell) (Zifivax) Approved for Emergency Use in Colombia2022-04-20
On January 22, 2022, Anhui Zhifei Longcom Biopharmaceutical Co., Ltd. (Zhifei Longcom), the wholly-owned subsidiary of Chongqing Zhifei Bio...
Recombinant COVID-19 Vaccine (CHO Cell) (Zifivax) Approved for Heterologous Booster in Indonesia2022-04-20
On January 10, 2022, National Agency of Drug and Food Control of Indonesia (BPOM) held a press conference to announce that our Recombinant ...